Introduction Myocarditis, inflammation of the heart muscle, can strike at any age. But children and adults do not always experience this disease the same way. A new review (Ricci et…

Introduction Myocarditis, inflammation of the heart muscle, can strike at any age. But children and adults do not always experience this disease the same way. A new review (Ricci et…
On Sunday, September 28th, there was a very special event planned by one of our Myocarditis Foundation’s Directors, Giustina Schiano. Giustina lost her adult son 10 years ago suddenly to…
Artificial Intelligence (AI) is rapidly changing how doctors gather and process medical information. In recent years, new AI tools have been developed that can scan large amounts of data, suggest…
Dr. Bettina Heidecker, one of our first Fellowship Grant recipients in 2007, has just been awarded a full professorship at the Charite University in Berlin. Dr. Heidecker’s newly established professorship…
On August 29, 2025, the European Society of Cardiology (ESC) released updated guidelines on diagnosing and managing myocarditis and pericarditis. These conditions, which involve inflammation of the heart muscle or its protective lining, have…
This past weekend, Dr. Leslie Cooper participated in a cardiology conference in Ottawa, Canada. Dr. Toshiyuki Nagai, Associate Professor in the Department of Medicine at Hokkaido University in Sapporo, Japan,…
On August 11th, 2025, the Myocarditis Foundation hosted its 18th annual golf outing at the beautiful Arcola Country Club in Paramus, New Jersey. The day was sunny and perfect for…
Pericarditis is inflammation of the thin sac that surrounds the heart, called the pericardium. While doctors have treated this condition for years, the American College of Cardiology recently released new 2025…
On behalf of the Myocarditis Foundation, we want to extend our deepest gratitude to everyone who joined us for our 20th Anniversary Celebration. Your presence meant so much to us,…
We’re excited to share that Kiniksa’s Pharmaceuticals Phase 2/3 clinical trial of KPL-387, a potential treatment for recurrent pericarditis, is now actively recruiting participants. If you or someone you know…